Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Down0.52% Nasdaq Down1.11%

Ligand Pharmaceuticals Incorporated (LGND)

-NasdaqGM

27.38 Down 0.36(1.30%) May 22, 4:00PM EDT|After Hours : 27.38 0.00 (0.00%) May 22, 4:31PM EDT

Add to Portfolio
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):1.7
Mean Recommendation (last week):1.7
Change:0.0

* (Strong Buy) 1.0 - 5.0 (Sell)Compare to Industry

Price Target Summary
Mean Target:34.33
Median Target:33.00
High Target:51.00
Low Target:25.00
No. of Brokers:6

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
Jan 3, 2013Cantor FitzgeraldDowngradeBuyHold
Jun 7, 2012Cantor FitzgeraldInitiated Buy
Jan 12, 2012Summer Street ResearchInitiated Buy
Jun 16, 2010C.K. CooperInitiated Buy
Jan 7, 2010MLVInitiated Buy
Aug 3, 2009MerrimanDowngradeBuyNeutral
Feb 11, 2009Merriman Curhan FordInitiated Buy
Jan 21, 2009OppenheimerInitiated Outperform
Nov 25, 2008Rodman & RenshawInitiated Mkt Outperform
Dec 6, 2007Susquehanna FinancialInitiated Positive

More Upgrades & Downgrades for LGND

Data provided by Briefing.com - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy3333
Buy2222
Hold1111
Underperform0000
Sell0000

Data provided by Thomson/First Call


Currency in USD.